Cite
HARVARD Citation
Bodewes, I. et al. (2018). TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis. Journal of autoimmunity. pp. 97-102. [Online].